Cargando…
The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer
BACKGROUND: Several surgeon characteristics are associated with the use of sentinel lymph node biopsy (SLNB) for breast cancer. No studies have systematically examined the relative contribution of both surgeon and hospital factors on receipt of SLNB. OBJECTIVE: To evaluate the relationship between s...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979807/ https://www.ncbi.nlm.nih.gov/pubmed/27495053 http://dx.doi.org/10.1097/MD.0000000000004392 |
_version_ | 1782447379613483008 |
---|---|
author | Yen, Tina W.F. Li, Jianing Sparapani, Rodney A. Laud, Purushuttom W. Nattinger, Ann B. |
author_facet | Yen, Tina W.F. Li, Jianing Sparapani, Rodney A. Laud, Purushuttom W. Nattinger, Ann B. |
author_sort | Yen, Tina W.F. |
collection | PubMed |
description | BACKGROUND: Several surgeon characteristics are associated with the use of sentinel lymph node biopsy (SLNB) for breast cancer. No studies have systematically examined the relative contribution of both surgeon and hospital factors on receipt of SLNB. OBJECTIVE: To evaluate the relationship between surgeon and hospital characteristics, including a novel claims-based classification of hospital commitment to cancer care (HC), and receipt of SLNB for breast cancer, a marker of quality care. DATA SOURCES/STUDY DESIGN: Observational prospective survey study was performed in a population-based cohort of Medicare beneficiaries who underwent incident invasive breast cancer surgery, linked to Medicare claims, state tumor registries, American Hospital Association Annual Survey Database, and American Medical Association Physician Masterfile. Multiple logistic regression models determined surgeon and hospital characteristics that were predictors of SLNB. RESULTS: Of the 1703 women treated at 471 different hospitals by 947 different surgeons, 65% underwent an initial SLNB. Eleven percent of hospitals were high-volume and 58% had a high commitment to cancer care. In separate adjusted models, both high HC (odds ratio [OR] 1.53, 95% confidence interval [CI] 1.12–2.10) and high hospital volume (HV, OR 1.90, 95% CI 1.28–2.79) were associated with SLNB. Adding surgeon factors to a model including both HV and HC minimally modified the effect of high HC (OR 1.34, 95% CI 0.95–1.88) but significantly weakened the effect of high HV (OR 1.25, 95% CI 0.82–1.90). Surgeon characteristics (higher volume and percentage of breast cancer cases) remained strong independent predictors of SLNB, even when controlling for various hospital characteristics. CONCLUSIONS: Hospital factors are associated with receipt of SLNB but surgeon factors have a stronger association. Since regionalization of breast cancer care in the U.S. is unlikely to occur, efforts to improve the surgical care and outcomes of breast cancer patients must focus on optimizing patient access to SLNB by ensuring hospitals have the necessary resources and training to perform SLNB, staffing hospitals with surgeons who specialize/focus in breast cancer and referring patients who do not have access to SLNB to an experienced center. |
format | Online Article Text |
id | pubmed-4979807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-49798072016-08-18 The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer Yen, Tina W.F. Li, Jianing Sparapani, Rodney A. Laud, Purushuttom W. Nattinger, Ann B. Medicine (Baltimore) 5750 BACKGROUND: Several surgeon characteristics are associated with the use of sentinel lymph node biopsy (SLNB) for breast cancer. No studies have systematically examined the relative contribution of both surgeon and hospital factors on receipt of SLNB. OBJECTIVE: To evaluate the relationship between surgeon and hospital characteristics, including a novel claims-based classification of hospital commitment to cancer care (HC), and receipt of SLNB for breast cancer, a marker of quality care. DATA SOURCES/STUDY DESIGN: Observational prospective survey study was performed in a population-based cohort of Medicare beneficiaries who underwent incident invasive breast cancer surgery, linked to Medicare claims, state tumor registries, American Hospital Association Annual Survey Database, and American Medical Association Physician Masterfile. Multiple logistic regression models determined surgeon and hospital characteristics that were predictors of SLNB. RESULTS: Of the 1703 women treated at 471 different hospitals by 947 different surgeons, 65% underwent an initial SLNB. Eleven percent of hospitals were high-volume and 58% had a high commitment to cancer care. In separate adjusted models, both high HC (odds ratio [OR] 1.53, 95% confidence interval [CI] 1.12–2.10) and high hospital volume (HV, OR 1.90, 95% CI 1.28–2.79) were associated with SLNB. Adding surgeon factors to a model including both HV and HC minimally modified the effect of high HC (OR 1.34, 95% CI 0.95–1.88) but significantly weakened the effect of high HV (OR 1.25, 95% CI 0.82–1.90). Surgeon characteristics (higher volume and percentage of breast cancer cases) remained strong independent predictors of SLNB, even when controlling for various hospital characteristics. CONCLUSIONS: Hospital factors are associated with receipt of SLNB but surgeon factors have a stronger association. Since regionalization of breast cancer care in the U.S. is unlikely to occur, efforts to improve the surgical care and outcomes of breast cancer patients must focus on optimizing patient access to SLNB by ensuring hospitals have the necessary resources and training to perform SLNB, staffing hospitals with surgeons who specialize/focus in breast cancer and referring patients who do not have access to SLNB to an experienced center. Wolters Kluwer Health 2016-08-07 /pmc/articles/PMC4979807/ /pubmed/27495053 http://dx.doi.org/10.1097/MD.0000000000004392 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 5750 Yen, Tina W.F. Li, Jianing Sparapani, Rodney A. Laud, Purushuttom W. Nattinger, Ann B. The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer |
title | The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer |
title_full | The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer |
title_fullStr | The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer |
title_full_unstemmed | The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer |
title_short | The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer |
title_sort | interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer |
topic | 5750 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979807/ https://www.ncbi.nlm.nih.gov/pubmed/27495053 http://dx.doi.org/10.1097/MD.0000000000004392 |
work_keys_str_mv | AT yentinawf theinterplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer AT lijianing theinterplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer AT sparapanirodneya theinterplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer AT laudpurushuttomw theinterplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer AT nattingerannb theinterplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer AT yentinawf interplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer AT lijianing interplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer AT sparapanirodneya interplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer AT laudpurushuttomw interplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer AT nattingerannb interplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer |